Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-IV: Nursing Management

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

C-terminal α<sub>1</sub>-antitrypsin peptides as pre-transplant biomarkers for chronic lung allograft dysfunction risk stratification.

ERJ open research·2026

Same author

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Transbronchial lung cryobiopsy: a safe and effective technique in the diagnosis of interstitial lung disease in the older people.

BMC geriatrics·2026

Same author

Blood eosinophilia as a predictor of acute exacerbation in fibrotic interstitial lung diseases.

Respiratory medicine·2026

Same author

Effect of Donor Age on Survival in Lung Transplantation: A Multicentric Retrospective Study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025

Same author

GLI Global equations for interstitial lung disease patients: shall we keep the baby, the bathwater or both?

ERJ open research·2025

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Preventing asthma exacerbations: what are the targets?

Karine Botturi¹, Marie Langelot, David Lair

¹INSERM, U915, Nantes, F-44000, France.

Pharmacology & Therapeutics

|March 29, 2011

Summary

Asthma exacerbations stem from two synergistic immune signals, leading to severe respiratory issues. Targeting these distinct inflammatory pathways offers potential for both preventing and treating asthma attacks.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Experiment Videos

Last Updated: Jun 3, 2026

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

Immunology
Pulmonology
Pharmacology

Background:

Asthma exacerbations are a primary cause of morbidity and mortality.
Two distinct immunological signals are required for exacerbations: chronic Th2 inflammation and acute Th1/Th2 inflammation.

Purpose of the Study:

To explore the immunological mechanisms underlying asthma exacerbations.
To identify potential therapeutic targets for both prevention and treatment of asthma attacks.

Main Methods:

Review of immunological pathways involved in asthma.
Analysis of molecular targets for chronic and acute inflammation.

Main Results:

Asthma exacerbations involve synergistic chronic (Th2) and acute (Th1/Th2) inflammation.
Innate and adaptive immunity play roles, offering therapeutic targets.
Toll-like receptors and epithelial cell cytokines are promising targets.

Conclusions:

Targeting chronic inflammation may prevent exacerbations, while targeting acute inflammation may treat them.
Asthma's heterogeneity necessitates personalized therapeutic approaches.
Integrative systems biology is crucial for advancing asthma treatment strategies.